Reactogenicity and Protectivity Following Measles- Rubella (MR) Routine Immunization in Indonesian Infants and Children

Tahapan Penelitian : Awal
Sponsor:
Mitra Pelaksana:
UNAIR/RS DR SOETOMO
No Registry
INA-BCER292
Tanggal Input Registry : 13-07-2018

04-09-2017
• To assess serious immediate systemic events within the first 30 minutes after Measles-Rubella (MR) vaccine in infants and children.
• To assess local reaction after Measles-Rubella (MR) vaccine in infants and children. • To assess systemic event after Measles-Rubella (MR) vaccine in infants and children. • To evaluate the protectivity against Measles and Rubella after 1 dose of MR vaccine in in infants and children. • To describe antibody response to Measles and Rubella after 1 dose of MR vaccine in infants and chidren.
 
Reactogenicity and Protectivity Following Measles- Rubella (MR) Routine Immunization in Indonesian Infants and Children
Reactogenicity and Protectivity Following Measles- Rubella (MR) Routine Immunization in Indonesian Infants and Children
Observasional
1 dose Measles Rubella (MR) vaccine
200
 

Inclusion Criteria:

• To assess serious immediate systemic events within the first 30 minutes after Measles-Rubella (MR) vaccine in infants and children.

Exclusion Criteria:

• To assess local reaction after Measles-Rubella (MR) vaccine in infants and children. • To assess systemic event after Measles-Rubella (MR) vaccine in infants and children. • To evaluate the protectivity against Measles and Rubella after 1 dose of MR vaccine in in infants and children. • To describe antibody response to Measles and Rubella after 1 dose of MR vaccine in infants and chidren.
 
No. 239/EC/KEPK/FKUA/2017
PMS MR 0417
Dr. dr. Dominicus Husada, SpA(K)